Q2 2021 Hansa Biopharma AB Earnings Call Transcript
Hello, and welcome to Hansa Biopharma Interim Report for January to June 2021. (Operator Instructions)
Today, I am pleased to present CEO, Søren Tulstrup. Please begin your meeting.
¸ - ()-&
Thank you, moderator. Good afternoon to those of you in Europe, and good morning to those in the U.S. Welcome to the Hansa Biopharma conference call on the first half results of 2021.
I'm Søren Tulstrup, CEO of Hansa. With me today, I have our CFO, Donato Spota; as well as our Head of Investor Relations, Klaus Sindahl.
Today, we'll review the overall progress and highlights of our business in the first half of 2021 and provide a preview of our near-term milestones. Our presentation should take around 15 minutes. And after that, we'll take your questions.
Turn to Slide 2. Please allow me to draw your attention to the fact that we'll be making forward-looking statements during this presentation, and you should
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |